Center for Precision Medicine in Oncology +Next the Patient (Q2908802): Difference between revisions
Jump to navigation
Jump to search
(Removed claim: co-financing rate (P837): 56.95 percentage) |
(Changed an Item: Import item from Portugal) |
||||||||||
| Property / budget | Property / budget | ||||||||||
| 999,375.77 Euro
| ||||||||||
| Property / EU contribution | Property / EU contribution | ||||||||||
| 569,144.5 Euro
| ||||||||||
| Property / priority axis | |||||||||||
| Property / priority axis: Enhancing the competitiveness of SMEs and reducing context-based public costs (TO 3 and TO2) / rank | |||||||||||
Normal rank | |||||||||||
| Property / co-financing rate | |||||||||||
56.95 percent
| |||||||||||
| Property / co-financing rate: 56.95 percent / rank | |||||||||||
Normal rank | |||||||||||
Revision as of 10:44, 8 November 2022
Project Q2908802 in Portugal
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Center for Precision Medicine in Oncology +Next the Patient |
Project Q2908802 in Portugal |
Statements
569,144.5 Euro
0 references
999,375.77 Euro
0 references
56.95 percent
0 references
1 June 2019
0 references
31 May 2021
0 references
INSTITUTO PORTUGUÊS DE ONCOLOGIA DE LISBOA FRANCISCO GENTIL E.P.E.
0 references
Identifiers
POCI-02-0550-FEDER-040602
0 references